Skip to main content
Premium Trial:

Request an Annual Quote

Medical Research Council Renews Sequencing Contract with Clinical Data’s Cogenics

NEW YORK, June 6 (GenomeWeb News) - Clinical Data said today that the UK's Medical Research Council has re-selected its Cogenics division as one of its three official DNA sequencing providers.


Cogenics is one of three units formed by Clinical Data in a March reorganization and represents the combined operations and marketing infrastructure of former CD companies Genaissance, Lark, and Icoria to provide comprehensive pharmacogenomics and molecular services.


Last week, Cambridge, UK-based Geneservice and German firm GATC Biotech also announced that they were selected as preferred sequencing vendors to the Medical Research Council.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.